Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Cancer Epidemiol 57:104109
doi: 10.1186/s12974-019-1627-9 174
Because heightened ROS levels drive pathology in several terrestrial disorders, this approach may also have therapeutic potential in diseases such as atherosclerosis, small-vessel disease, obesity, and type 2 diabetes
Controlled Release at the Site of Action Liposomes release their payload gradually or in response to specific triggers (such as changes in skin temperature or lipid environment)
89 A study of nondiabetic patients with severe obesity showed that 3 months of exenatide treatment improved fasting and postprandial lipidomic profiles (reduced saturated triacylglycerols, ceramides, and lysophosphatidylcholines) while increasing cardioprotective unsaturated phospholipid species
US$ 25.75
US$ 22.55
US$ 23.49
